Research

VU study identifies new gene fusions in melanoma

Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer.

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

Cancer drug enhances cognition

The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.

Manager of mitotic stress

The protein CK1 delays cell division to avoid the generation of defects that drive tumorigenesis.

Study to explore new technologies to connect doctors, patients outside medical settings

A five-year study to explore new technologies that automate patient care outside of hospitals and doctors’ offices will identify ways technology can provide real-time feedback and guidance to patients and to alert care coordination teams before health issues escalate.

Therapeutic target for gastric cancer

A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies.

1 153 154 155 156 157 210